SEDEC Trademark

Trademark Overview


On Friday, October 8, 2021, a trademark application was filed for SEDEC with the United States Patent and Trademark Office. The USPTO has given the SEDEC trademark a serial number of 97066220. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Thursday, August 22, 2024. This trademark is owned by Sedec Therapeutics, Inc.. The SEDEC trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune diseases, neurological diseases, and cancer; medications, namely, orally administrated pills, topical cream, and subcutaneous injection; chemical preparations for medical purposes, namely, for the treatment of autoimmune diseases, neurological diseases, and cancer; chemical preparations for therapeutical purposes, namely, orally administrated pills, topical cream, and subcutaneous injection, for the treatment of autoimmune diseases, neurological diseases, and cancer; autoimmune disease medications, namely, orally administrated pills, topical cream, and subcutaneous injection; cancer immunotherapy medications, namely, orally administrated pills, topical cream, subcutaneous injection, immunoassay reagents for medical use; pharmaceutical preparations for the prevention and treatment of autoimmune diseases or disorders; pharmaceutical preparations for cancer immunotherapy
sedec

General Information


Serial Number97066220
Word MarkSEDEC
Filing DateFriday, October 8, 2021
Status732 - THIRD EXTENSION - GRANTED
Status DateThursday, August 22, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 17, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of autoimmune diseases, neurological diseases, and cancer; medications, namely, orally administrated pills, topical cream, and subcutaneous injection; chemical preparations for medical purposes, namely, for the treatment of autoimmune diseases, neurological diseases, and cancer; chemical preparations for therapeutical purposes, namely, orally administrated pills, topical cream, and subcutaneous injection, for the treatment of autoimmune diseases, neurological diseases, and cancer; autoimmune disease medications, namely, orally administrated pills, topical cream, and subcutaneous injection; cancer immunotherapy medications, namely, orally administrated pills, topical cream, subcutaneous injection, immunoassay reagents for medical use; pharmaceutical preparations for the prevention and treatment of autoimmune diseases or disorders; pharmaceutical preparations for cancer immunotherapy
Translation of Words in MarkThe English translation of SEDEC in the mark is sixteen.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 1, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSedec Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNatick, MA 01760

Party NameSedec Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNatick, MA 01760

Trademark Events


Event DateEvent Description
Tuesday, December 6, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 12, 2021NEW APPLICATION ENTERED
Monday, November 1, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 13, 2022ASSIGNED TO EXAMINER
Friday, July 29, 2022NON-FINAL ACTION WRITTEN
Friday, July 29, 2022NON-FINAL ACTION E-MAILED
Friday, July 29, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 6, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, December 6, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, December 6, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, December 12, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 12, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 13, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 13, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 28, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 17, 2023PUBLISHED FOR OPPOSITION
Tuesday, January 17, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 14, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, September 11, 2023SOU EXTENSION 1 FILED
Monday, September 11, 2023SOU TEAS EXTENSION RECEIVED
Monday, September 11, 2023SOU EXTENSION 1 GRANTED
Wednesday, September 13, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 12, 2024SOU EXTENSION 2 FILED
Tuesday, March 12, 2024SOU EXTENSION 2 GRANTED
Tuesday, March 12, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, March 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 22, 2024SOU TEAS EXTENSION RECEIVED
Thursday, August 22, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 22, 2024SOU EXTENSION 3 GRANTED
Thursday, August 22, 2024SOU EXTENSION 3 FILED